Frank Verheyen

1.6k total citations
53 papers, 1.2k citations indexed

About

Frank Verheyen is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Frank Verheyen has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in General Health Professions, 19 papers in Public Health, Environmental and Occupational Health and 12 papers in Economics and Econometrics. Recurrent topics in Frank Verheyen's work include Health and Medical Studies (13 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Clinical practice guidelines implementation (10 papers). Frank Verheyen is often cited by papers focused on Health and Medical Studies (13 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Clinical practice guidelines implementation (10 papers). Frank Verheyen collaborates with scholars based in Germany, Switzerland and United States. Frank Verheyen's co-authors include Roland Linder, Thomas Wilke, A. Groth, S. Mueller, M. Pfannkuche, Rupert Bauersachs, Ulf Maywald, Susanne Engel, G. Breithardt and Tobias Effertz and has published in prestigious journals such as PLoS ONE, BMC Public Health and Thrombosis and Haemostasis.

In The Last Decade

Frank Verheyen

51 papers receiving 1.1k citations

Peers

Frank Verheyen

CCM

GHP

EPIDE

SURGE

Anuja Roy United States

Meghan J. Elliott Canada

Natasha Burke Canada

Anne-Françoise Gaudin France

Björn Stollenwerk Germany

Christel Castelli France

Itziar Etxeandia‐Ikobaltzeta United States

Betina T. Blak United Kingdom

Adrian Brady United Kingdom

Siân Harrison United Kingdom

Anuja Roy United States

Frank Verheyen

219 ×0.6

CCM

148 ×0.7

GHP

167 ×1.0

EPIDE

344 ×2.3

142 ×1.0

SURGE

Citations per year, relative to Frank Verheyen Frank Verheyen (= 1×) peers Anuja Roy

Countries citing papers authored by Frank Verheyen

Since Specialization

Citations

This map shows the geographic impact of Frank Verheyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Verheyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Verheyen more than expected).

Fields of papers citing papers by Frank Verheyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Verheyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Verheyen. The network helps show where Frank Verheyen may publish in the future.

Co-authorship network of co-authors of Frank Verheyen

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Verheyen. A scholar is included among the top collaborators of Frank Verheyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Verheyen. Frank Verheyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Linder, Roland, et al.. (2017). Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?. The European Journal of Health Economics. 19(6). 821–830. 4 indexed citations

Neubauer, Stefan, Tobias Schilling, Jan Zeidler, et al.. (2016). Auswirkung einer leitliniengerechten Behandlung auf die Mortalität bei Linksherzinsuffizienz. Herz. 41(7). 614–624. 9 indexed citations

Neubauer, Stefan, Jan Zeidler, Tobias Schilling, et al.. (2016). Eignung und Anwendung von GKV-Routinedaten zur Überprüfung von Versorgungsleitlinien am Beispiel der Indikation Linksherzinsuffizienz. Das Gesundheitswesen. 78(S 01). e135–e144. 4 indexed citations

Kollhorst, Bianca, et al.. (2016). Comparative risk for cardiovascular diseases of dipeptidyl peptidase-4 inhibitors vs. sulfonylureas in combination with metformin: Results of a two-phase study. Journal of Diabetes and its Complications. 30(7). 1339–1346. 4 indexed citations

Schneider, Udo, Roland Linder, & Frank Verheyen. (2015). Long-term sick leave and the impact of a graded return-to-work program: evidence from Germany. The European Journal of Health Economics. 17(5). 629–643. 31 indexed citations

Zeidler, Jan, et al.. (2015). Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -. Health Economics Review. 5(1). 40–40. 17 indexed citations

Effertz, Tobias, Susanne Engel, Frank Verheyen, & Roland Linder. (2015). The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective. The European Journal of Health Economics. 17(9). 1141–1158. 60 indexed citations

Linder, Roland, et al.. (2015). Disease-Management-Programme. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58(4-5). 345–351. 10 indexed citations

Zeidler, Jan, et al.. (2015). Alters- und geschlechtsspezifische Kosten sowie die Versorgung mit medikamentösen Therapien von ADHS-Patienten. Das Gesundheitswesen. 78(7). e23–e29. 5 indexed citations

10.

Röttger, Julia, Miriam Blümel, Susanne Engel, et al.. (2015). Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) – Study Design and Methodology. International Journal of Health Policy and Management. 4(7). 431–437. 19 indexed citations

11.

Пантели, Димитра, Caroline S. Wagner, Frank Verheyen, & Reinhard Busse. (2015). Continuity of care in the cross-border context: insights from a survey of German patients treated abroad. European Journal of Public Health. 25(4). 557–563. 9 indexed citations

12.

Klein, S., et al.. (2014). Frakturen und Versorgungskosten bei Osteoporose: Analyse von Krankenkassen-Routinedaten im Rahmen der Bone Evaluation Study (BEST). Journal für Kardiologie (Krause & Pachernegg GmbH). 21(4). 121–125. 1 indexed citations

13.

Beyer, Martin, Corina Güthlin, Barbara Hoffmann, et al.. (2014). Das hausärztliche Fehlerberichts- und Lernsystem ‚jeder-fehler-zaehlt.de‘ – Berichtsbestand und Nutzungsperspektiven. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 109(1). 62–68. 5 indexed citations

14.

Blankart, Carl Rudolf, et al.. (2013). Cost of illness and economic burden of chronic lymphocytic leukemia. Orphanet Journal of Rare Diseases. 8(1). 32–32. 28 indexed citations

15.

Wilke, Thomas, A. Groth, S. Mueller, et al.. (2012). Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. EP Europace. 15(4). 486–493. 267 indexed citations

16.

Wilke, Thomas, A. Groth, S. Mueller, et al.. (2012). How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus. The European Journal of Health Economics. 14(3). 551–568. 20 indexed citations

17.

Braun, Sebastian, Jan Zeidler, Roland Linder, et al.. (2012). Treatment costs of attention deficit hyperactivity disorder in Germany. The European Journal of Health Economics. 14(6). 939–945. 23 indexed citations

18.

Linder, Roland, et al.. (2011). The Benefit and Efficiency of the Disease Management Program for Type 2 Diabetes. Deutsches Ärzteblatt international. 108(10). 155–62. 46 indexed citations

19.

Genz, Jutta, Burkhard Haastert, Gabriele Meyer, et al.. (2010). Blood glucose testing and primary prevention of diabetes mellitus type 2 - evaluation of the effect of evidence based patient information. BMC Public Health. 10(1). 15–15. 7 indexed citations

20.

Scherbaum, W. A., et al.. (2006). Nachweis eines bisher unerkannten Diabetes mellitus Typ 2 mittels Risikofragebogen. DMW - Deutsche Medizinische Wochenschrift. 131(40). 2208–2212. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact